My work focuses mainly on cognitive aspects of multiple sclerosis (MS). I am Co-Chair of the Brief International Cognitive Assessment for MS initiative (www.BICAMS.net), which has many countries in the international validation pipeline (of whom 30 have published to date) and has been recommended by the American Academy of Neurology. There are a further 135 peer reviewed articles reporting experiments using BICAMS to explore MS cognition. My other research interests include Benefits and Risks of MS Medication (BRIMMS), an evidence-based protocol that presents information about disease modifying drugs in a way that increases the understanding of people with MS; developing the Motor Planning Index, a measure of cerebellar function for MS; how young people with MS use health information websites; and how cognition relates to the employment experience of people with MS. I have been neuropsychology lead on many international trials of MS medication and natural history, for pharma. I am on the steerng group of MS in the 21st Century, a group of people with MS and health professionals who publish papers, collect data and develop tools to improve MS healthcare (www.msinthe21stcentury.com). I am also on the steering group of the International MS Cognition Society (www.IMSCOGS.com) and the steering group of the new IMSCOGS/ECTRIMS cognition guidelines initiative. I am a Trustee of the UK MS Trust (www.mstrust.org) and author of their online cognition tool for people with MS (www.stayingsmart.org). I am a Fellow of the British Psychological Society and an Honorary Professor in the Preventative Neurology Unit within the Wolfson Institute, Queen Mary University of London.